SCI Journal

Impact Factor Database

Therapeutic Advances in Hematology

Impact Factor

3.456

H Index

27

Impact Factor

NA

Therapeutic Advances in Hematology

Basic Journal Info

Country

United States
Journal ISSN: 20406207, 20406215
Publisher: SAGE Publications
History: 2010-2016
Journal Hompage: Link
How to Get Published:

Research Categories

Therapeutic Advances in Hematology
2020 Impact Factor by Web of Science

Index

SCIE/SSCI

Impact Factor

3.456

by WOS

Ranking

2535

by WOS

Therapeutic Advances in Hematology
2020 SJR, SJR Impact Factor and H Index

H Index

27

SJR

NA

Scopus Impact Factor

NA

Therapeutic Advances in Hematology
2020 SJR Impact Factor 2-year, 3-year, 4-year

2-year
Impact Factor

NA

3-year
Impact Factor

NA

4-year
Impact Factor

NA

Scope/Description:

Therapeutic Advances in Hematology delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of blood disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in hematology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of hematology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies - all phases. Letters to the Editor and Case Reports will also be considered. Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.

Therapeutic Advances in Hematology
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Therapeutic Advances in Hematology
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Therapeutic Advances in Hematology
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?

See what other people are reading

Discover

Therapeutic Advances in Hematology
SCR Journal Impact Factor History

  • 2020 Impact Factor NA
  • 2019 Impact Factor 0
  • 2018 Impact Factor NA
  • 2017 Impact Factor NA
  • 2016 Impact Factor 3.614
  • 2015 Impact Factor 3.354
  • 2014 Impact Factor 2.545
  • 2013 Impact Factor 0.556
  • 2012 Impact Factor 0.561
  • 2011 Impact Factor 0.25
  • 2010 Impact Factor 0
  • 2009 Impact Factor NA
  • 2008 Impact Factor NA
  • 2007 Impact Factor NA
  • 2006 Impact Factor NA
  • 2005 Impact Factor NA
  • 2004 Impact Factor NA
  • 2003 Impact Factor NA
  • 2002 Impact Factor NA
  • 2001 Impact Factor NA
  • 2000 Impact Factor NA
Note: impact factor data for reference only

See what other people are reading

Discover

Other Journal Impact Indicator

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Therapeutic Advances in Hematology

H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

27

Therapeutic Advances in Hematology

SCImago Journal Rank (SJR)

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

NA